| Developers: | DNA Technology |
| Date of the premiere of the system: | 2023/01/27 |
| Branches: | Pharmaceuticals, Medicine, Healthcare |
2023: Test Development
The metropolitan company "DNA-Technology" has developed three types of tests to assess the risk of giving birth to a child with hereditary diseases. This was announced on January 27, 2023 by the head of the Department of Investment and Industrial Policy of Moscow, which is part of the Complex of Economic Policy and Property and Land Relations of the capital, Vladislav Ovchinsky.
AneuScreen ILM test, thanks to which in the first months of pregnancy it is possible to assess the risks of aneuploidia and chromosomal abnormalities in the fetus. It is a non-invasive method of prenatal screening for aneuploidias, based on analysis of fetal extracellular DNA in the mother's blood. Read more here.
See also
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |